CFI advised Oceanaa Biotek Industries Limited on its sale of a minority stake to B R Traders
Mumbai – CFI India acted as the exclusive corporate finance advisor to Oceanaa Biotek Industries Limited on the sale of a minority stake to B R Traders. The transaction was privately negotiated.
B R Traders is a privately held company. Oceanaa Biotek Industries Limited engages in producing and trading prawn seeds in India. The company also operates a food testing laboratory that provides microbiological, molecular biology, and chemical analysis for food. In addition, it offers a range of courses for training employees, students, and professionals in food processing and various related fields. The company was formerly known as Oceanic Shelters Private Limited and changed its name to Oceanaa Biotek Industries Limited in May 2013. Oceanaa Biotek Industries Limited was incorporated in 2005 and is based in Chennai, India.
CFI India was hired to provide assistance in the acquisition of assets of the Seller Partnership Firm M/s. B R Traders and to provide assistance at which shares were issued to a partnership firm as purchase consideration.
The transaction closed on 22 February 2017.
Healthcare & Life Sciences

has sold a minority stake to B R Traders
Transaction details
B R Traders acquires a 24.81% stake in Oceanaa Biotek Industries Limited, a company that engages in producing and trading prawn seeds in India, in a privately negotiated transaction
This transaction was advised by:

Raj Shroff
Partner, Managing DirectorOur latest transactions
Software & IT Services

have sold

to

a portfolio company of
Transaction details
Technology field services and support provider Vista Technology Support has been acquired by TRG
Consumer Goods & Retail

has obtained fundraising from
Transaction details
High-end bicycle producer The Rider Firm has obtained fundraising from Santander
Software & IT Services

has raised growth capital from
Transaction details
Digital Pills, an Italian Data & AI consulting company, has sold a minority stake to Equiter, raising funds for its future growth

